November 1 - 3, 2018
Las Vegas, NV



CME/CE Credit

Learning Objectives

At the conclusion of this live conference, participants should be better able to:

  • Develop a comprehensive treatment plan for acne patients based on clinical guidelines, incorporating pharmacologic and nonpharmacologic strategies.
  • Describe risk factors for actinic keratosis and squamous cell carcinoma.
  • Select appropriate therapeutic strategies for alopecia areata and other hair disorders based on patients’ needs and desires.
  • Apply treatment strategies for patients with atopic dermatitis based on disease severity with the goal of clear or almost clear skin.
  • Incorporate strategies for use of use of new therapies aimed at blocking the inflammatory mediators of atopic dermatitis.
  • Identify treatment options for all stages of melanoma.
  • Demonstrate in-depth understanding of onychomycosis and tinea treatments, including drug interactions and warnings regarding therapy in patients with comorbid disease or receiving other medications.
  • Describe the pathophysiology of psoriasis and the associated comorbidities of the disease.
  • Diagnose and treat patients with psoriasis appropriately, based on current clinical guidelines.
  • Compare and contrast safety and efficacy data on new and emerging therapies for psoriasis.
  • Integrate biologic therapies into the management of appropriately selected patients with psoriasis.
  • Monitor patient response to psoriasis therapy and modify the treatment strategy as needed.
  • Apply treatment strategies, based on knowledge of the indications, efficacy, and risks of available rosacea therapies, to achieve therapeutic goals in rosacea treatment.
  • Develop a treatment plan to address hypertrophic scars and keloids.
  • Differentiate seborrheic keratosis from other skin lesions, particularly melanoma
  • Match patients with the most appropriate interventions for effective and cosmetically acceptable treatment of SK lesions.
  • Discuss the latest data on the prevalence, severity, and impact of primary axillary hyperhidrosis and other common forms of hyperhidrosis.
  • Summarize the efficacy and safety of fillers, toxins, devices, and techniques currently available in aesthetic and procedural dermatology.
  • Identify the considerations in the selection of appropriate filler agents for treating different areas of the face.
  • Compare and contrast the efficacy and safety of agents, devices, and techniques currently available in aesthetic and procedural dermatology.
  • Implement the appropriate nonsurgical techniques for facial rejuvenation.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville and Global Academy for Medical Education, LLC. The University of Louisville is accredited by the ACCME to provide continuing education for physicians.

The University of Louisville Office of Continuing Medical Education & Professional Development designates this live activity for a maximum of 17.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AAFP Credit
This Live activity, Skin Disease Education Foundation's 19th Las Vegas Dermatology Seminar & 15th Psoriasis Forum, with a beginning date of 11/01/2018, has been reviewed and is acceptable for up to  17.0 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The self-assessment program offered at the Skin Disease Education Foundation’s 19th Las Vegas Dermatology Seminar® is approved by the American Board of Dermatology (ABD) for MOC-D self-assessment points.



 In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 17.0 contact hours (1.75 CEUs) of the Accreditation Council for Pharmacy Education.

Type of Activity

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 17.0 contact hours.

Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.


Follow Us

Jointly Provided By

In Association With